Search research articles
Contact Us
Filters
Showing results (61-70 of 189) with videos related to
Page
of 19
Sort By:
Journal of Pharmaceutical and Biomedical Analysis
|
February 15, 2011
A direct ELISA assay for quantitative determination of the inhibitory potency of small molecules inhibitors for JNK3
Márcia Goettert, Sabine Luik, Ralph Graeser, et al.
Expert Opinion on Therapeutic Patents
|
May 21, 2015
c-Jun N-terminal kinase inhibitors: a patent review (2010 - 2014)
Matthias Gehringer, Felix Muth, Pierre Koch, et al.
Life Sciences
|
July 4, 1983
Cycloamylose complexation of adamantane derivatives
R I Gelb, L M Schwartz, D A Laufer
Journal of Medicinal Chemistry
|
October 4, 2002
Imidazole inhibitors of cytokine release: probing substituents in the 2 position
Stefan A Laufer, Hans-Günther Striegel, Gerd K Wagner
Angewandte Chemie (International Ed. in English)
|
October 11, 2017
The Cysteinome of Protein Kinases as a Target in Drug Development
Apirat Chaikuad, Pierre Koch, Stefan A Laufer, et al.
Mutation Research. Reviews in Mutation Research
|
November 6, 2023
Applications of advanced technologies for detecting genomic structural variation
Vincent A Laufer, Thomas W Glover, Thomas E Wilson
Journal of Clinical Psychology
|
October 1, 1981
Purpose in life and occupational interest in a gerontological sheltered workshop
W S Laufer, E A Laufer, L S Laufer
Journal of Medicinal Chemistry
|
June 10, 1994
(6,7-Diaryldihydropyrrolizin-5-yl)acetic acids, a novel class of potent dual inhibitors of both cyclooxygenase and 5-lipoxygenase
S A Laufer, J Augustin, G Dannhardt, et al.
Clinical Orthopaedics and Related Research
|
May 1, 1985
Aggressive osteoblastoma. A case report and review of the literature
S Kenan, Y Floman, G C Robin, et al.
Expert Opinion on Therapeutic Patents
|
April 2, 2020
An updated patent review of p38 MAP kinase inhibitors (2014-2019)
Vanessa Haller, Philipp Nahidino, Michael Forster, et al.
Page
of 19
Search research articles
Search
Showing results (61-70 of 189) with videos related to
Sort By:
Page
of 19
Journal of Pharmaceutical and Biomedical Analysis
|
February 15, 2011
A direct ELISA assay for quantitative determination of the inhibitory potency of small molecules inhibitors for JNK3
Márcia Goettert, Sabine Luik, Ralph Graeser, et al.
Expert Opinion on Therapeutic Patents
|
May 21, 2015
c-Jun N-terminal kinase inhibitors: a patent review (2010 - 2014)
Matthias Gehringer, Felix Muth, Pierre Koch, et al.
Life Sciences
|
July 4, 1983
Cycloamylose complexation of adamantane derivatives
R I Gelb, L M Schwartz, D A Laufer
Journal of Medicinal Chemistry
|
October 4, 2002
Imidazole inhibitors of cytokine release: probing substituents in the 2 position
Stefan A Laufer, Hans-Günther Striegel, Gerd K Wagner
Angewandte Chemie (International Ed. in English)
|
October 11, 2017
The Cysteinome of Protein Kinases as a Target in Drug Development
Apirat Chaikuad, Pierre Koch, Stefan A Laufer, et al.
Mutation Research. Reviews in Mutation Research
|
November 6, 2023
Applications of advanced technologies for detecting genomic structural variation
Vincent A Laufer, Thomas W Glover, Thomas E Wilson
Journal of Clinical Psychology
|
October 1, 1981
Purpose in life and occupational interest in a gerontological sheltered workshop
W S Laufer, E A Laufer, L S Laufer
Journal of Medicinal Chemistry
|
June 10, 1994
(6,7-Diaryldihydropyrrolizin-5-yl)acetic acids, a novel class of potent dual inhibitors of both cyclooxygenase and 5-lipoxygenase
S A Laufer, J Augustin, G Dannhardt, et al.
Clinical Orthopaedics and Related Research
|
May 1, 1985
Aggressive osteoblastoma. A case report and review of the literature
S Kenan, Y Floman, G C Robin, et al.
Expert Opinion on Therapeutic Patents
|
April 2, 2020
An updated patent review of p38 MAP kinase inhibitors (2014-2019)
Vanessa Haller, Philipp Nahidino, Michael Forster, et al.
Page
of 19